{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Laura Brunelli"}, {"accession": "MS:1000589", "name": "contact email", "value": "laura.brunelli@marionegri.it"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "IRCCS Istituto Ricerche Farmacologiche Mario Negri"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Roberta Pastorelli"}, {"accession": "MS:1000589", "name": "contact email", "value": "roberta.pastorelli@marionegri.it"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "IRCCS-Istituto Ricerche Farmacologiche Mario Negri"}]}], "datasetFiles": [{"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007838/C2_R1.RAW"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007838/C2_R2.RAW"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007838/C2_R3.RAW"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007838/K4_R1_dil.RAW"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007838/K4_R2.RAW"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007838/K4_R3.RAW"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007838/c77_R1.RAW"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007838/c77_R2.RAW"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007838/c77_R3.RAW"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007838/k40_R1.RAW"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007838/k40_R2.RAW"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007838/k40_R3.RAW"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007838/SEARCH.txt"}], "description": "Since  both KRAS mutations  and LKB1 inactivating  alterations  affect  cellular  metabolism,  it  seems propitious to discern metabolic effects induced by the single oncogenic events from those elicited by their  co-occurrence,  with  the  ultimate  aim  to  potentially  exploit  metabolic  dependencies  for  novel therapeutic modalities. With these considerations in mind, we knocked-out the LKB1 gene in well-characterized  NSCLC  cell  clones  harboring  KRAS  WT or  mutant  G12C  proteins  (13,30).  We obtained an isogenic system in which KRAS mutation and LKB1 inactivation were individually or concomitantly present. The effects of the genetic lesions individually or together on cell metabolism were  investigated  in  these  isogenic  NSCLC  cells  by means  of  an  integrated  survey  of proteomics, stable and dynamic metabolomics and functional in-vitro strategies.", "fullDatasetLinks": [{"accession": "MS:1002852", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007838"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD007838"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD007838"}], "instruments": [{"accession": "MS:1000449", "name": "LTQ Orbitrap"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "protepmics KRAS mutation LKB1 deletion"}, {"accession": "MS:1002340", "name": "ProteomeXchange project tag", "value": "Cancer (B/D-HPP)"}, {"accession": "MS:1002340", "name": "ProteomeXchange project tag", "value": "Biology/Disease-Driven Human Proteome Project (B/D-HPP)"}, {"accession": "MS:1001926", "name": "curator keyword", "value": "Biological"}, {"accession": "MS:1002340", "name": "ProteomeXchange project tag", "value": "Human Proteome Project"}, {"accession": "MS:1001926", "name": "curator keyword", "value": "Biomedical"}], "modifications": [{"accession": "MOD:00425", "name": "monohydroxylated residue"}, {"accession": "MOD:00397", "name": "iodoacetamide derivatized residue"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "30514331"}, {"accession": "MS:1002866", "name": "Reference", "value": "Caiola E, Falcetta F, Giordano S, Marabese M, Garassino MC, Broggini M, Pastorelli R, Brunelli L. Co-occurring KRAS mutation/LKB1 loss in non-small cell lung cancer cells results in enhanced metabolic activity susceptible to caloric restriction: an in vitro integrated multilevel approach. J Exp Clin Cancer Res. 2018 37(1):302"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Label Free proteomics on NSCLC isogenic cell lines"}